|

AZD9574 Clinical Trials

4 actively recruiting trials across 4 locations

▲ +1 trial since June 2026

Pipeline

Phase 1/2: 4

Top Sponsors

  • AstraZeneca4

Indications

  • Cancer4
  • Metastatic Prostate Cancer2
  • Lung Squamous Cell Carcinoma1
  • Lung Adenocarcinoma1
  • Endometrial Cancer1

Fayetteville, Arkansas1 trial

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Research Site

Phase 1/2

Duarte, California1 trial

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Research Site

Phase 1/2

Encino, California1 trial

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Research Site

Phase 1/2

La Jolla, California1 trial

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.